13th Annual World Multispecific Summit
20
Sep
-
22
Sep
2022
When
Boston
Massachusetts
USA
Where

The Newly Re-Branded 13th World Multispecifics Summit is the Only End-to-End Meeting Committed Solely to Advancing the Development of Bi- & Multi-Specific Therapeutics With more clinical candidates and commercial success than ever within this rapidly developing space, multi-specifics is evidently the fourth wave of drug discovery.

Similar Events

You May Like

Event

Hanson Wade

0/5
(0)

Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.

20 - 22 Sep 2022
In-Person

Speakers and Delegates
Industry Experts and Thought Leaders

Dept. Head Biologics Core Technologies
Senior Scientist II- Enzymology & Biophysics
Vice President, Protein Sciences and Rational Design
Principal Scientific Researcher - Antibody Engineering
Project Leader Innate Immune Cell Engager
Chief Scientific Officer

Sponsors and Exhibitors
Brand, Media and Promotional Partners

Applied BioMath

Founded in 2013, Applied BioMath uses mathematical modeling and simulation to provide quantitative and predictive guidance to biotechnology and pharmaceutical companies to help accelerate and de-risk drug research and development.

Beacon Targeted Therapies

Make faster and better informed drug development decisions In partnership with the world’s leading drug development experts to help you keep up with the pace of preclinical and clinical research developments.

AlivaMab Discovery Services

AlivaMab Discovery Services is a leader in the discovery of antibody therapeutics, trusted by top-tier pharmaceutical and biotechnology companies to deliver panels of drug-quality human antibodies.

Carterra

Carterra is a leading provider of innovative technologies designed to accelerate the discovery of novel therapeutic candidates.

Asimov

Asimov builds tools to program living cells. By integrating mammalian synthetic biology, computer-aided design, and machine learning, our multi-disciplinary team is advancing the design and manufacture of biologics and gene therapies.

BSP Pharmaceuticals S.p.A.

BSP Pharmaceuticals S.p. A. is focused on the development and manufacturing of anticancer drugs with high potency and cytotoxitc characteristics for the Pharmaceuticals Industry. BSP has been at the forefront in the fight agains cancer since 2006.

Ligand Pharmaceuticals

Ligand is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines.

GemPharmatech

GemPharmatech Co. Ltd., founded in 2017, is an international biotechnology enterprise specializing in the development of humanized animal models. The management and operation team has nearly 20 years of experience in gene-editing technology and anima

Organizer

Get emails from us

Thank you
Oops! Something went wrong